[294 Pages Report] The global non-invasive pulse wave tonometer market size is expected to be valued at US$ 104.3 Million in 2022. Blood flow in the body should be proper to maintain health and also reduce the risk of heart and other problems associated with blood flow. As the blood flow starts its journey from the heart and flows through various veins and arteries. Blood is a very good carrier that can carry nutrients and drugs to different parts of the body.
Data Points | Key Statistics |
---|---|
Non-invasive Pulse Wave Tonometer Market Value 2022 | US$ 104.3 Million |
Non-invasive Pulse Wave Tonometer Market Projected Value (2032) | US$ 194 Million |
Non-invasive Pulse Wave Tonometer Market CAGR (2022 to 2032) | 5.8% |
The non-invasive pulse wave tonometer is a very good device that can help to understand the flow pattern and provide the information so that the proper treatment can be provided. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around US$ 194 Million by 2032.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 4.7%. The proper monitoring of blood flow helps to manage the flow of blood and also help the doctors and another healthcare professional to monitor the patients for various disorders such as COPD (Chronic Obstructive Pulmonary Disease), hypertension, and other problem, non-invasive pulse wave tonometer is used mainly consider for the heart-related problem. Nowadays most treatment centers are using these devices.
Non-invasive pulse wave tonometer is mostly used for monitoring blood flow and understanding the various diseases, to provide treatment. Various innovations are going on for developing the product to provide real-time monitoring of flow and provide treatment. The increasing number of patients and technological enhancement is the major potential for the non-invasive pulse wave tonometer market. The overall demand for non-invasive pulse wave tonometers is projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around US$ 194 Million by 2032.
Increased Product Innovation Likely to Augment Non-invasive Pulse Wave Tonometer Sales
Non-invasive pulse wave tonometer is a growing market over the forecast period, as the number of patients is increasing related to heart, hypertension, and others. According to the British Lung Foundation, approx. 1.2 million people are suffering from COPD. The number of patients who are suffering from heart-related problems is also increasing in every region of the world.
The players are also coming up with new product innovations to make the product portable and provide in-depth monitoring of blood flow. The major strength of the system is that it can monitor the flow of blood non-invasive, while in the traditional case, the catheter was inserted to monitor the flow.
High Rates of Investment to Impede the Growth
Although Non-invasive Pulse Wave Tonometer offers good ROI in the long run, the high initial investment is a deterrent for many organizations.
The high cost along with awareness and viability of the product the hinderers of the non-invasive pulse wave tonometer market.
Rising Market Competition to Boost the Market Growth in North America
The North American non-invasive pulse wave tonometer market is expected to accumulate a market share of 33.7% in 2022. North America is dominating and contributing the leading shares to the non-invasive pulse wave tonometer market in terms of revenue and is expected to register significant growth over a forecast period due to the increasing market competition.
The rising prevalence of glaucoma in the region is also adding to the market growth. According to the American Academy of Ophthalmology (AAO), glaucoma affects over 2.7 million of the population aged 40 and older in the USA
Rising Prevalence of Glaucoma Risk Factors to Boost Market Growth in Europe
The European region is anticipated to hold a market share of 30.8%. According to the WHO, there are over 60 million people living with diabetes in the European region. This is mainly due to rising behavioral risk factors such as smoking, alcohol consumption, unhealthy food habits, and a sedentary lifestyle.
Europe is expected to contribute to moderate revenue market share and register a healthy growth rate in the global Non-invasive Pulse Wave Tonometer market due to the rising prevalence of glaucoma risk factors such as diabetes, myopia, and hypertension in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some key start-ups in the Non-invasive Pulse Wave Tonometer market include:
Prominent players in the Non-invasive Pulse Wave Tonometer market are ADInstruments, Millar, DiaTecne s.r.l. and AtCor Medical Pty Ltd., and various other regional players.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 5.8% from 2022 to 2032 |
Market Value in 2022 | US$ 104.3 Million |
Market Value in 2032 | US$ 194 Million |
Base Year for Estimation | 2021 |
Historical Data | 2016 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in US$ Million and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available upon Request |
As of 2022, the Non-invasive Pulse Wave Tonometer market is slated to reach a valuation of US$ 104.3 Million
From 2022 to 2032, sales of Non-invasive Pulse Wave Tonometer is expected to grow at a 5.8% CAGR
By 2032, Future Market Insights expects the Non-invasive Pulse Wave Tonometer market to reach US$ 194 Million.
1. Executive Summary | Non-invasive Pulse Wave Tonometer Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Analysis 2016 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ million) Analysis, 2016 to 2021 4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Indication 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Indication, 2016 to 2021 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Indication, 2022 to 2032 5.3.1. Hypertension 5.3.2. Renal Disease 5.3.3. COPD 5.3.4. Diabetes 5.3.5. Heart Failure 5.3.6. Others 5.4. Y-o-Y Growth Trend Analysis By Indication, 2016 to 2021 5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032 6. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By End User, 2016 to 2021 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals 6.3.2. Clinics 6.3.3. Others 6.4. Y-o-Y Growth Trend Analysis By End User, 2016 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Analysis 2016 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ million) Analysis By Region, 2016 to 2021 7.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. South Asia 7.3.5. East Asia 7.3.6. Oceania 7.3.7. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 8.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. The USA 8.2.1.2. Canada 8.2.2. By Indication 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Indication 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Indication 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Indication 9.3.3. By End User 9.4. Key Takeaways 10. Europe Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. The United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Indication 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Indication 10.3.3. By End User 10.4. Key Takeaways 11. South Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. India 11.2.1.2. Malaysia 11.2.1.3. Singapore 11.2.1.4. Thailand 11.2.1.5. Rest of South Asia 11.2.2. By Indication 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Indication 11.3.3. By End User 11.4. Key Takeaways 12. East Asia Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Indication 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Indication 12.3.3. By End User 12.4. Key Takeaways 13. Oceania Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Indication 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Indication 13.3.3. By End User 13.4. Key Takeaways 14. MEA Analysis 2016 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2016 to 2021 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Indication 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Indication 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Analysis 15.1. The USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Indication 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Indication 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Indication 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Indication 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Indication 15.5.2.2. By End User 15.6. The United Kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Indication 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Indication 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Indication 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Indication 15.9.2.2. By End User 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Indication 15.10.2.2. By End User 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Indication 15.11.2.2. By End User 15.12. Singapore 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Indication 15.12.2.2. By End User 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Indication 15.13.2.2. By End User 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Indication 15.14.2.2. By End User 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Indication 15.15.2.2. By End User 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Indication 15.16.2.2. By End User 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Indication 15.17.2.2. By End User 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Indication 15.18.2.2. By End User 15.19. GCC Countries 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Indication 15.19.2.2. By End User 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Indication 15.20.2.2. By End User 15.21. Israel 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2021 15.21.2.1. By Indication 15.21.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Indication 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. ADInstruments 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Millar 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. DiaTecne s.r.l. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. AtCor Medical Pty Ltd. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Haag Streit AG 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Ametek Industries Technology 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Ray Vision International Corporation 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Crystalvue Medical 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Shanghai Vowish Optical Co., Ltd. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports